Diabetes

Subcutaneous exendin treats post-bariatric hypoglycemia

(HealthDay)—Subcutaneous exendin (SC Ex-9) appears to be safe and effective in treating post-bariatric hypoglycemia (PBH), according to a study published online Aug. 4 in Diabetes, Obesity and Metabolism.

Diabetes

Similar defects ID'd for T2DM, chronic pancreatitis and diabetes

(HealthDay)—Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia, according to a study published online ...

Diabetes

New blood test may better predict gestational diabetes

A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity ...

Diabetes

Maternal hyperglycemia ups offspring cardiometabolic risk

(HealthDay)—Maternal hyperglycemia during pregnancy is associated with increased risk of abnormal glucose tolerance, obesity, and increased blood pressure (BP) in offspring, independent of maternal obesity, according to ...

Diabetes

Intensive medical treatment can reverse type 2 diabetes

Type 2 diabetes can be reversed with intensive medical treatment using oral medications, insulin and lifestyle therapies, according to a study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

page 2 from 5